Pharma Aids declares 35% cash dividend for FY26

The company’s profit rose 37% year-on-year to Tk8.75 crore in FY26, while its board recommended a higher dividend than the previous year.

Pharma Aids, a leading glass ampoule manufacturer for Bangladesh’s pharmaceutical industry, reported a 37% year-on-year increase in profit to Tk8.75 crore in FY2025-26, with earnings per share (EPS) rising to Tk28.05.

Buoyed by the higher earnings, the pharmaceutical and chemical sector company recommended a 35% cash dividend for shareholders, up from 30% in the previous fiscal year.

However, following the earnings and dividend announcement, Pharma Aids’ share price fell 3.85% to Tk521 at the Dhaka Stock Exchange (DSE).

Regarding the dividend payouts, the company said that the 35% cash dividend is recommended keeping in mind the necessity of funds for land acquisition and construction of new factory buildings as part of the upcoming BMRE project.

According to its disclosure, the net asset value per share stood at Tk163.31 and the net operating cash flow per share stood at Tk24.57, which was Tk138.58 and Tk12.74 each for the year ended on 30 June 2025.

The annual general meeting scheduled on 15 December through the digital platform and to identify its shareholders for entitling dividend, record date has been fixed on 25 November.

As of October, out of its total outstanding shares, sponsor-directors held 19.38%, institutional investors 19.68% and the general public held 60.94%, according to data from the DSE.

The company got listed on the stock exchanges in 1987, and its current paid-up capital stood at Tk3.12 crore.

Source: The Business Standard